Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of $0.07, $0.04 better than the analyst estimate of $0.03. Revenue for the quarter came in at $37.4 million versus the consensus estimate of $35.63 million.

GUIDANCE:

Aspen Aerogels sees FY2016 EPS of ($0.15)-($0.06). Aspen Aerogels sees FY2016 revenue of $117-122 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.